These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 16953145)
61. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Ritchie SA; Connell JM Nutr Metab Cardiovasc Dis; 2007 May; 17(4):319-26. PubMed ID: 17110092 [TBL] [Abstract][Full Text] [Related]
62. Insulin resistance and hypertension in the absence of subcutaneous fat. Chaudhuri A; Izzo JL Rev Cardiovasc Med; 2000; 1(2):120-4. PubMed ID: 12457148 [TBL] [Abstract][Full Text] [Related]
63. Metabolic syndrome and liver transplantation: a review and guide to management. Watt KD; Charlton MR J Hepatol; 2010 Jul; 53(1):199-206. PubMed ID: 20451282 [TBL] [Abstract][Full Text] [Related]
64. Clinical observation paper: fatty liver and metabolic syndrome: is it a burden for the future generations? Nobili V; Agostoni C Metabolism; 2010 Jun; 59(6):831-3. PubMed ID: 20005539 [No Abstract] [Full Text] [Related]
70. Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment--a position paper of the The Obesity Society and The American Society of Hypertension. Landsberg L; Aronne LJ; Beilin LJ; Burke V; Igel LI; Lloyd-Jones D; Sowers J Obesity (Silver Spring); 2013 Jan; 21(1):8-24. PubMed ID: 23401272 [TBL] [Abstract][Full Text] [Related]
71. Effects of weight loss and pharmacotherapy on inflammatory markers of cardiovascular disease. Miller WM; Nori Janosz KE; Yanez J; McCullough PA Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):743-59. PubMed ID: 16076283 [TBL] [Abstract][Full Text] [Related]
72. Origins of metabolic complications in obesity: adipose tissue and free fatty acid trafficking. Mittendorfer B Curr Opin Clin Nutr Metab Care; 2011 Nov; 14(6):535-41. PubMed ID: 21849896 [TBL] [Abstract][Full Text] [Related]
73. The dysmetabolic syndrome: epidemiology and etiology. Sauerwein HP Nestle Nutr Workshop Ser Clin Perform Programme; 2006; 11():1-13. PubMed ID: 16820727 [TBL] [Abstract][Full Text] [Related]
74. Metabolic syndrome, a cardiovascular disease risk factor: role of adipocytokines and impact of diet and physical activity. Robinson LE; Graham TE Can J Appl Physiol; 2004 Dec; 29(6):808-29. PubMed ID: 15630152 [TBL] [Abstract][Full Text] [Related]
76. [Metabolic syndrome: convergence of metabolic diseases based on obesity and dysfunction of adipose tissue]. Masuzaki H; Tanaka T; Nakao K Nihon Rinsho; 2006 Dec; 64 Suppl 9():17-22. PubMed ID: 17458189 [No Abstract] [Full Text] [Related]
77. Fat as an endocrine organ: relationship to the metabolic syndrome. Hutley L; Prins JB Am J Med Sci; 2005 Dec; 330(6):280-9. PubMed ID: 16355012 [TBL] [Abstract][Full Text] [Related]
78. The biology of the metabolic syndrome and aging. Dominguez LJ; Barbagallo M Curr Opin Clin Nutr Metab Care; 2016 Jan; 19(1):5-11. PubMed ID: 26560521 [TBL] [Abstract][Full Text] [Related]
79. Is all fat the same? The role of fat in the pathogenesis of the metabolic syndrome and type 2 diabetes mellitus. Hansen E; Hajri T; Abumrad NN Surgery; 2006 Jun; 139(6):711-6. PubMed ID: 16782424 [No Abstract] [Full Text] [Related]
80. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Matsuzawa Y; Funahashi T; Nakamura T Ann N Y Acad Sci; 1999 Nov; 892():146-54. PubMed ID: 10842660 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]